Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Lou

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nature Cancer|February 24, 2026
The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinationsJohnny X Yu, Jung Min Suh, Katerina D Popova, et al.
Journal of Medicinal Chemistry|July 4, 2014
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathiesKevin Lou, Yuemang Yao, Adam T Hoye, et al.
Science (New York, N.Y.)|December 14, 2019
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibitionKeelan Z Guiley, Jack W Stevenson, Kevin Lou, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Programmable translational inhibition by a molecular glue-oligonucleotide conjugateSiyi Wang, Joanna R Kovalski, Francisco J Zapatero-Belinchón, et al.
Science (New York, N.Y.)|December 8, 2022
IFITM proteins assist cellular uptake of diverse linked chemotypesKevin Lou, Douglas R Wassarman, Tangpo Yang, et al.
Neuro-Oncology Advances|January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Science Signaling|May 30, 2019
KRAS<sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependenciesKevin Lou, Veronica Steri, Alex Y Ge, et al.
Leukemia|July 31, 2024
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminibAriel Leyte-Vidal, RosaAnna DeFilippis, Ian R Outhwaite, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma PatientsK Ina Ly, Leland G Richardson, Mofei Liu, et al.
Biology Open|July 25, 2018
Extending chemical perturbations of the ubiquitin fitness landscape in a classroom setting reveals new constraints on sequence toleranceDavid Mavor, Kyle A Barlow, Daniel Asarnow, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nature Cancer|February 24, 2026
The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinationsJohnny X Yu, Jung Min Suh, Katerina D Popova, et al.
Journal of Medicinal Chemistry|July 4, 2014
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathiesKevin Lou, Yuemang Yao, Adam T Hoye, et al.
Science (New York, N.Y.)|December 14, 2019
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibitionKeelan Z Guiley, Jack W Stevenson, Kevin Lou, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Programmable translational inhibition by a molecular glue-oligonucleotide conjugateSiyi Wang, Joanna R Kovalski, Francisco J Zapatero-Belinchón, et al.
Science (New York, N.Y.)|December 8, 2022
IFITM proteins assist cellular uptake of diverse linked chemotypesKevin Lou, Douglas R Wassarman, Tangpo Yang, et al.
Neuro-Oncology Advances|January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Science Signaling|May 30, 2019
KRAS<sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependenciesKevin Lou, Veronica Steri, Alex Y Ge, et al.
Leukemia|July 31, 2024
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminibAriel Leyte-Vidal, RosaAnna DeFilippis, Ian R Outhwaite, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma PatientsK Ina Ly, Leland G Richardson, Mofei Liu, et al.
Biology Open|July 25, 2018
Extending chemical perturbations of the ubiquitin fitness landscape in a classroom setting reveals new constraints on sequence toleranceDavid Mavor, Kyle A Barlow, Daniel Asarnow, et al.
Pageof 3